Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Debt/Equity

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Total Debt/Equity History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Total Debt/Equity(x) 0.250.130.460.400.67

What is the latest Total Debt/Equity ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Debt/Equity ratio of GLENMARK PHARMACEUTICALS is 0.25 based on Mar2025 Consolidated results.
Year Total Debt/Equity
Mar20250.25
Mar20240.13
Mar20230.46
Mar20220.40
Mar20210.67

How is Total Debt/Equity of GLENMARK PHARMACEUTICALS Trending?

Years Total Debt/Equity % Change
Mar2025 0.25
92.31
Mar2024 0.13
-71.74
Mar2023 0.46
15.00
Mar2022 0.4
-40.30
Mar2021 0.67 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Total Debt/Equity ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹61,237.4 Cr 2.5% 7.7% 60.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,000.0 Cr -0.4% 5.3% 13.4% Stock Analytics
DIVIS LABORATORIES ₹161,076.0 Cr -4.3% -6.3% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,510.0 Cr 0.4% 8.2% 44.7% Stock Analytics
DR REDDYS LABORATORIES ₹107,921.0 Cr 0.5% 1.8% 16.4% Stock Analytics
CIPLA ₹106,150.0 Cr -0.8% -2.6% -9.2% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

2.5%

7.7%

60.5%

SENSEX

-5.5%

-11.5%

0.3%


You may also like the below Video Courses